For research use only. Not for therapeutic Use.
Cidofovir(Cat No.:A000312)is an antiviral medication used primarily in the treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those with HIV/AIDS. It works by inhibiting viral DNA polymerase, preventing viral replication. Cidofovir is effective against a range of DNA viruses, including herpesviruses. Its use is typically reserved for severe CMV infections due to its nephrotoxic effects. As a nucleotide analogue, Cidofovir requires intravenous administration and is often combined with probenecid to reduce nephrotoxicity. It’s critical to monitor kidney function during treatment to mitigate adverse effects.
Catalog Number | A000312 |
CAS Number | 113852-37-2 |
Synonyms | Vistide; 113852-37-2; HPMPC; Cidofovir anhydrous; (S)-HPMPC |
Molecular Formula | C8H14N3O6P |
Purity | ≥95% |
Target | Apoptosis |
Solubility | Limited solubility |
Storage | -20°C |
IUPAC Name | [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid |
InChI | InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 |
InChIKey | VWFCHDSQECPREK-LURJTMIESA-N |
SMILES | C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O |
Reference | 1: Smith SDB, Erdag G, Cuda JD, Rangwala S, Girardi N, Bibee K, Orens JB, 2: Jones SEF, Hibbitts S, Hurt CN, Bryant D, Fiander AN, Powell N, Tristram AJ. 3: Arora R, Jasmita, Singh M, Garg A, Gupta M, Gupta N. Successful Treatment of <br> 5: Ip MH, Coroneo MT. Treatment of Previously Refractory Ocular Surface Squamous <br> 7: Catalani S, Palma F, Battistelli S, Nuvoli B, Galati R, Benedetti S. Reduced 8: Pi Sala N, Figueras Suriol A, Ramió Montero E. [Intralesional cidofovir in <br> 10: Lee M, Kim S, Kwon OJ, Kim JH, Jeong I, Son JW, Na MJ, Yoon YS, Park HW, Kwon |